Literature DB >> 25454866

Investigation of immunity in sheep following footrot infection and vaccination.

Vidya Bhardwaj1, Om Dhungyel1, Kumudika de Silva2, Richard J Whittington1.   

Abstract

Ovine footrot is a major disease affecting sheep welfare and production. The anaerobic Gram-negative bacterium Dichelobacter nodosus is the essential transmitting agent. Monovalent or bivalent vaccines induce high levels of D. nodosus antibodies and are the basis of several successful footrot treatment, control and eradication programs. Due to the rapid rate of disease transmission within a flock, the presence of therapeutic vaccination non-responders has major implications for a control program. The aim of this study was to assess the immunological basis of a therapeutic vaccination non-response. Sheep (n=120) were infected with D. nodosus in an artificial pen challenge. Once disease had established, animals were vaccinated with a serogroup specific D. nodosus fimbrial vaccine. Based on the response to therapeutic vaccination, animals were allocated into one of three groups: (i) TVNR where disease persisted despite vaccination (ii) non-diseased, where disease never established and (iii) TVR, where disease was established but resolved with vaccination. Factors related to both the innate and adaptive immune pathways were assessed. These included antigen-specific serum antibodies, interferon-γ, interleukin-10, proliferation of lymphocyte subsets and phagocytic activity of leukocytes. There was no significant difference between the three groups of sheep for any of these parameters. All three groups of sheep produced antibody in excess of a previously published minimum antibody titre required for protection. Opsonising activity in sera from the three groups of sheep was also not significantly different and phagocytic cells from sheep from all three groups were able to destroy D. nodosus intracellularly. These findings show that the measured systemic adaptive and innate immune responses were unlikely to be the cause of a therapeutic vaccination non-response. They also show that the accepted minimum protective titre may be incorrect and may need further examination.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody response; Cell mediated immune response; Dichelobacter nodosus; Footrot; Phagocytosis; Vaccination efficacy

Mesh:

Substances:

Year:  2014        PMID: 25454866     DOI: 10.1016/j.vaccine.2014.10.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Structural Diversity in the Type IV Pili of Multidrug-resistant Acinetobacter.

Authors:  Kurt H Piepenbrink; Erik Lillehoj; Christian M Harding; Jason W Labonte; Xiaotong Zuo; Chelsea A Rapp; Robert S Munson; Simeon E Goldblum; Mario F Feldman; Jeffrey J Gray; Eric J Sundberg
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

2.  A Novel 3D Skin Explant Model to Study Anaerobic Bacterial Infection.

Authors:  Grazieli Maboni; Rebecca Davenport; Kate Sessford; Kerstin Baiker; Tim K Jensen; Adam M Blanchard; Sean Wattegedera; Gary Entrican; Sabine Tötemeyer
Journal:  Front Cell Infect Microbiol       Date:  2017-09-14       Impact factor: 5.293

3.  A distinct bacterial dysbiosis associated skin inflammation in ovine footrot.

Authors:  Grazieli Maboni; Adam Blanchard; Sara Frosth; Ceri Stewart; Richard Emes; Sabine Tötemeyer
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

4.  Characterization of two putative Dichelobacter nodosus footrot vaccine antigens identifies the first lysozyme inhibitor in the genus.

Authors:  Maria Victoria Humbert; Alexandra Jackson; Christian M Orr; Ivo Tews; Myron Christodoulides
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.